tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
AstraZeneca plc (GB:AZN)
:AZN
UK Market
AZN
AstraZeneca
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

AstraZeneca (AZN) Stock News & Sentiment

Compare
738 Followers
AstraZeneca’s Phase III Study on Baxdrostat and Dapagliflozin: A Potential Game-Changer for CKD Treatment
Premium
Company Announcements
AstraZeneca’s Phase III Study on Baxdrostat and Dapagliflozin: A Potential Game-Changer for CKD Treatment
23h ago
AZN
AstraZeneca’s New Trial on Benralizumab: A Potential Game-Changer for Pediatric Eosinophilic Diseases
Premium
Company Announcements
AstraZeneca’s New Trial on Benralizumab: A Potential Game-Changer for Pediatric Eosinophilic Diseases
23h ago
AZN
AstraZeneca’s Ongoing Study on Ovarian Cancer: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s Ongoing Study on Ovarian Cancer: Key Insights for Investors
23h ago
AZN
AstraZeneca’s AZD6234 Study: A Potential Game-Changer for Renal Impairment Treatment
Premium
Company Announcements
AstraZeneca’s AZD6234 Study: A Potential Game-Changer for Renal Impairment Treatment
23h ago
AZN
AstraZeneca’s Promising CAR T-Cell Therapy Study: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s Promising CAR T-Cell Therapy Study: Key Insights for Investors
23h ago
AZN
AstraZeneca’s Promising Phase 2b Study on AZD2693 for NASH: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s Promising Phase 2b Study on AZD2693 for NASH: Key Insights for Investors
23h ago
AZN
AstraZeneca’s Latest CKD Study: Potential Market Impact
Premium
Company Announcements
AstraZeneca’s Latest CKD Study: Potential Market Impact
23h ago
AZN
More GB:AZN News >

AZN News on the Web

AstraZeneca’s New Study on AZD5004: Potential Market Implications
TipRanks News
Neutral
Ex-dividend day weighs heavily on the FTSE this week
Proactive Investors
Neutral
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
CNBC
Neutral
Trump's drug price ultimatum sets pharma firms scrambling
CNBC
Neutral
Tariff turmoil: How global CEOs are shifting gears
CNBC
Neutral
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
CNBC
Neutral
Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
CNBC
Neutral
AstraZeneca gets clean bill of health from leading investment bank
Proactive Investors
Neutral

News Score - Last 7 Days

Neutral
GB:AZN
Sector Average
Media Buzz
This Week3 articles
Weekly Average7 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:AZN’s Media Buzz Sentiment?
3 articles about GB:AZN were published this week. In an average week, 7 articles are published.
    What is GB:AZN’s weekly average amount of articles?
    In an average week, 7 articles about GB:AZN are published.
      What is GB:AZN’s News Sentiment?
      50% of articles about GB:AZN were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        IMCRImmunocore Holdings
        CRMDCormedix
        RIGLRigel
        FARNFaron Pharmaceuticals Oy
        HALOHalozyme
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing